Dr. Laderian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Avenue
Cleveland, OH 44195- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Hematology and Medical Oncology, 2017 - 2020
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2014 - 2017
- University of Pittsburgh School of MedicineClass of 2014, MD
Certifications & Licensure
- NY State Medical License 2017 - 2025
- OH State Medical License 2020 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Young Investigator Award American Society of Clinical Oncology, 2019
Clinical Trials
- LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) Start of enrollment: 2019 Jun 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 11 citationsTargeting TRK: A fast-tracked application of precision oncology and future directions.Arsenije Kojadinovic, Bahar Laderian, Prabhjot S. Mundi> ;Critical Reviews in Oncology/hematology. 2021 Aug 10
- 27 citationsEmerging Therapeutic Implications of STK11 Mutation: Case SeriesBahar Laderian, Prabhjot S. Mundi, Tito Fojo, Susan E. Bates> ;The Oncologist. 2020 Sep 1
- 2 citationsDistribution of cancer genes in human chromosomes.Bahar Laderian, Mengxi Zhou, Tito Fojo> ;Seminars in Oncology. 2020 Jun 19
- Join now to see all
Abstracts/Posters
- A closer look at next generation sequencing (NGS) in breast cancer: A retrospective analysisBahar Laderian, ANA CRISTINA Sandoval Leon, Loulwa Alsharhan, Dorraya El Ashry, Marc E. Lippman, ASCO 2017, Chicago, IL
- Complete Blood Count Parameters as Predictive Factors in Patients with Advanced Non-Small Cell Lung Cancer Treated with NivolumabDiana Saravia Bahar Laderian Wungki Park Adrian Ishkanian Lisa Balfe Mohammad Jahanzeb, IASLC, Vienna, Austria
- Comparison of Gender, Race Distribution, and Survival in the 1990s to 2010s in Lung Cancer Patients at a Single InstitutionBahar Laderian, Diana Saravia, Ali Laderian, Adrian Ishkanian, Mohammad Jahanzeb5 1, IASLC, Vienna, Austria
- Join now to see all
Grant Support
- Young Investigator AwardASCOPresent
Hospital Affiliations
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
- Cleveland ClinicCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: